Visa Restrictions On Central American Nationals Working With The CCP To Undermine Rule Of Law In Central America
The United States is committed to countering China’s corrupt influence in Central America and stop its attempts to subvert rule of law. Today, the Department of State is announcing a new visa restriction policy that will allow our nation to restrict U.S. visas for Central American nationals who, while in Central American countries and intentionally acting on behalf of the Chinese Communist Party (CCP), knowingly direct, authorize, fund, provide significant support to, or carry out activities that undermine the rule of law in Central America. We are also taking steps to impose these visa restrictions under this new policy on a number of Central American nationals who have previously engaged in such activities. As a result, these individuals and their immediate family members will be generally ineligible for entry into the United States.
These actions reaffirm President Trump’s commitment to protect America’s economic prosperity and national security interests in our region. We continue to promote accountability for Central American nationals who intentionally work with the CCP in Central America and destabilize our hemisphere.
We continue to use all available tools to promote safety and security of our region.
These actions are being taken pursuant to Section 212(a)(3)(C) of the Immigration and Nationality Act.

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Latin America Mobile Payment Market To Hit USD 1,688.0 Billion By 2033
- BTCC Announces Participation In Token2049 Singapore 2025, Showcasing NBA Collaboration With Jaren Jackson Jr.
- PLPC-DBTM: Non-Cellular Oncology Immunotherapy With STIPNAM Traceability, Entering A Global Acquisition Window.
- Bitget Launches PTBUSDT For Futures Trading And Bot Integration
- Ecosync & Carboncore Launch Full Stages Refi Infrastructure Linking Carbon Credits With Web3
- Bitmex And Tradingview Announce Trading Campaign, Offering 100,000 USDT In Rewards And More
Comments
No comment